Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

504
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
504
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

357
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
357
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

1.6K
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
1.6K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

388
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
388
Varicose Veins I: Introduction01:26

Varicose Veins I: Introduction

238
Varicose veins, or varicosities, are abnormally dilated and twisted superficial veins caused by venous valve incompetence. This condition commonly affects the lower extremities, especially the saphenous veins, due to the higher pressure from prolonged standing and walking. However, varicosities can also occur in other areas, such as the esophagus, vulva, spermatic cords, and anorectal region.Etiology and typesPrimary varicose veins, often idiopathic, are more common in women due to inherent...
238
Veins of the Abdomen and Pelvis01:18

Veins of the Abdomen and Pelvis

1.9K
The human body is a complex system of interconnected parts, and the circulatory system plays a crucial role in maintaining overall health. One key component of this system is the inferior vena cava, a large vein responsible for returning blood from the abdominopelvic viscera and abdominal walls to the heart.
The inferior vena cava is fed by numerous smaller veins. The lumbar veins, for instance, drain the posterior abdominal wall, emptying both directly into the inferior vena cava and into the...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of a pan-ELastography Machine-learning (ELM) score to predict clinically significant portal hypertension in compensated advanced chronic liver disease.

Journal of hepatology·2026
Same author

Mapping of class II HLA restriction of SepSecS-specific CD4 T cell epitopes in autoimmune hepatitis.

JHEP reports : innovation in hepatology·2026
Same author

Pre-liver transplant assessment of patients with acute-on-chronic liver failure: An international survey.

JHEP reports : innovation in hepatology·2026
Same author

Employment and work absenteeism in individuals living with a vascular liver disease: a European multicenter study.

Clinics and research in hepatology and gastroenterology·2026
Same author

API-CAT Investigators' Decisions on Anticoagulation following Extended Treatment for Cancer VTE.

European heart journal. Cardiovascular pharmacotherapy·2026
Same author

Another step toward phenotypic characterization of hereditary dysfibrinogenemia?

Research and practice in thrombosis and haemostasis·2026

Related Experiment Video

Updated: Feb 17, 2026

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
08:45

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

Published on: June 27, 2025

1.6K

[Splanchnic vein thrombosis].

Bobby Gouin1, Helia Robert-Ebadi2, Alessandro Casini2

  • 1Service de médecine interne, Centre hospitalier universitaire de Sherbrooke, 3001, 12e avenue Nord, Sherbrooke, J1H 5N4, Québec, Canada.

Revue Medicale Suisse
|December 7, 2017
PubMed
Summary
This summary is machine-generated.

Splanchnic vein thromboses, rare venous thromboembolisms, require individualized anticoagulation. Careful assessment of bleeding risk due to portal hypertension is crucial for optimal patient management.

More Related Videos

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography
06:44

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography

Published on: April 13, 2018

10.5K
Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension
04:00

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension

Published on: November 15, 2024

833

Related Experiment Videos

Last Updated: Feb 17, 2026

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
08:45

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

Published on: June 27, 2025

1.6K
Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography
06:44

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography

Published on: April 13, 2018

10.5K
Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension
04:00

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension

Published on: November 15, 2024

833

Area of Science:

  • Vascular Medicine
  • Gastroenterology
  • Hematology

Background:

  • Splanchnic vein thromboses (SVT) encompass portal venous system and hepatic vein thrombosis (Budd-Chiari syndrome).
  • These rare venous thromboembolisms are often linked to local or systemic factors.
  • Management is complex due to patient heterogeneity and limited data.

Purpose of the Study:

  • To outline the diagnostic and therapeutic challenges of splanchnic vein thromboses.
  • To emphasize the importance of anticoagulation as the primary treatment.
  • To highlight the necessity of individualized treatment strategies considering bleeding risks.

Main Methods:

  • Review of current literature on splanchnic vein thromboses.
  • Analysis of treatment approaches and associated risks.
  • Description of a multidisciplinary consultation approach for patient management.

Main Results:

  • Anticoagulation is the cornerstone of SVT treatment.
  • Bleeding risk, particularly from portal hypertension, necessitates careful evaluation.
  • Individualized treatment plans are essential for effective management.

Conclusions:

  • Optimal management of SVT requires a thorough assessment of bleeding risks.
  • Multidisciplinary collaboration is vital for complex cases.
  • Further research is needed to refine treatment guidelines for these rare conditions.